Palanas, Jane D.

HRN: 23-90-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/22/2023
10/29/2023
IV
2.25g
Q6
AGN; UTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: